Zai Lab Limited ADR [ZLAB] stock is trading at $36.08, up 15.90%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ZLAB shares have gain 19.15% over the last week, with a monthly amount glided 16.58%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zai Lab Limited ADR [NASDAQ: ZLAB] stock has seen the most recent analyst activity on March 07, 2025, when Scotiabank initiated its Sector Outperform rating and assigned the stock a price target of $55. Previously, BofA Securities downgraded its rating to Neutral on March 03, 2025, and elevated its price target to $36.10. On December 14, 2023, Morgan Stanley initiated with a Overweight rating and assigned a price target of $47.50 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $70 on August 10, 2023. Macquarie initiated its recommendation with a Outperform and recommended $64 as its price target on January 21, 2022. In a note dated April 28, 2020, Goldman initiated an Buy rating.
Zai Lab Limited ADR [ZLAB] stock has fluctuated between $16.01 and $39.77 over the past year. Currently, Wall Street analysts expect the stock to reach $55 within the next 12 months. Zai Lab Limited ADR [NASDAQ: ZLAB] shares were valued at $36.08 at the most recent close of the market. An investor can expect a potential return of 52.44% based on the average ZLAB price forecast.
Analyzing the ZLAB fundamentals
Zai Lab Limited ADR [NASDAQ:ZLAB] reported sales of 418.33M for the trailing twelve months, which represents a growth of 22.19%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -0.64%, Pretax Profit Margin comes in at -0.6%, and Net Profit Margin reading is -0.6%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.33 and Total Capital is -0.31. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Zai Lab Limited ADR’s Current Ratio is 3.26. Also, the Quick Ratio is 3.09, while the Cash Ratio stands at 2.37. Considering the valuation of this stock, the price to sales ratio is 9.47, the price to book ratio is 4.82.
Transactions by insiders
Recent insider trading involved Chen Yajing, Chief Financial Officer, that happened on Jun 02 ’25 when 9618.0 shares were sold. Officer, Chen Yajing completed a deal on Jun 02 ’25 to buy 9618.0 shares. Meanwhile, Chairperson & CEO Du Ying sold 50000.0 shares on May 13 ’25.
